Launch of COVID-19 antibody test

Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has launched a CE-Mark approved serology (antibody) 96-well plate ELISA (enzyme-linked immunosorbent assay) test for the detection of IgG antibodies to SARS-CoV-2 derived from plasma and

Visit Page

Appointment of ODDO BHF

Paris, France and Camberley, UK – 28 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the appointment of ODDO BHF, an independent Franco-German financial services group, for the initiation of equity research coverage in France for the Company. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Appointment-of-ODDO-BHF-ENGLISH-28.09.2020.pdf

Visit Page

AGM voting

Paris, France and Camberley, UK – 18 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM) as a closed meeting at 2pm CEST/1pm BST on 29 September 2020. As usual, and in accordance with French corporate law, the AGM comprises both

Visit Page